CJC/IPA.
DISCLAIMER: THIS PRODUCT IS INTENDED FOR RESEARCH USE ONLY. THIS PRODUCT IS DESIGNED EXCLUSIVELY FOR LAWFUL IN VITRO LABORATORY RESEARCH AND ANALYTICAL APPLICATIONS. THE INFORMATION PROVIDED ON THIS W...
Lab Verified
Clinical Grade
PMID Cited
Mechanism of Action.
Published preclinical research has characterized the following molecular pathways and receptor interactions for CJC/IPA.
Receptor Binding
This compound interacts with specific receptor sites characterized in published preclinical research models.
Signal Transduction
Published studies have examined downstream signaling effects in cell culture and tissue models.
Gene Expression
Research indicates modulation of gene expression profiles in targeted tissue preparations.
Cellular Response
Functional assays in preclinical models have characterized cellular response patterns.
Clinical Literature
Research review on CJC/IPA molecular characterization.
Preclinical studies have characterized the molecular properties and receptor binding profiles of CJC/IPA in standardized assay systems.
CJC/IPA structure-activity relationship analysis.
Structure-activity relationship studies have examined the functional domains and binding characteristics of CJC/IPA in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
Related Compounds.
GH SecretagoguesCJC no DAC
$43.00C152H252N44O42 · 3367.9 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesFOXO4
$196.00C228H388N86O64 · 5358.06 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesIpamorelin
$28.00C38H49N9O5 · 711.87 g/mol
For in vitro research use only. Not for human consumption.